# Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I)

> **NCT02262364** · PHASE1 · COMPLETED · sponsor: **Zimmer Biomet** · enrollment: 11 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **BIOLOGICAL:** APS

## Key facts

- **NCT ID:** NCT02262364
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02262364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02262364, "Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02262364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*